[Hyperbaric oxygenotherapy for fybromialga, peripheral vascular disease, neurological disease and other indications]

Carmona Rodríguez M, García Carpintero EE, Hernández Torres A
Record ID 32018001720
Original Title: Oxigenoterapia hiperbárica en el tratamiento de fibromialgia, enfermedad vascular periférica, enfermedad neurológica y otras indicaciones
Authors' objectives: To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) in patients with fibromyalgia, neurological disease, peripheral vascular disease and other indications, in order to have information to assess its possible inclusion in the portfolio of services
Authors' results and conclusions: The treatment of the studied conditions is multi-therapeutic and it’s carried out together with others such as analgesia, vascularization, debridement, antibiotherapy and rehabilitation, among others. The introduction of HBOT is not a substitutive treatment, but an additional co-adjuvant intervention, which improves significantly the therapeutic results in some very specific cases. 2) HBOT has been shown to be effective in the treatment of: a) Fibromyalgia to improve sensitivity to pain, pain and quality of life. b) Brain injury to improve Glasgow Scale values and mortality. c) Multiple sclerosis with restricted efficacy to improvement of the EDSS scale and pyramidal function. d) Vascular disease to improve cure and healing rates and, in some cases, amputations, whether major or minor. e) Mandibular osteonecrosis in short-term healing. f) Post-radiation injuries in bladder voiding, Lent/Soma scale and pain in the short term (3-6 months), alveolar necrosis or patients with necrosis and some dimensions of quality of life in the long term (12 months). 3) No evidence or inconclusive results have been found for the efficacy of HBOT in the indications of refractory migraine, stroke, compartment syndromes, osteomyelitis and soft tissue infection. 4) Except in the absolute contraindications described for receiving HBOT, adopting the necessary precautions, in certain pathologies or clinical situations. HBOT appears to be effective, used appropriately, for selected individuals and at the right time, with minimal margin for side effects.
Authors' methods: Systematic Review
Project Status: Completed
Year Published: 2020
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Spain
MeSH Terms
  • Hyperbaric Oxygenation
  • Fibromyalgia
  • Peripheral Vascular Diseases
  • Neurology
  • Multiple Sclerosis
  • Radiation Injuries
  • Hyperbaric oxygen therapy; Fibromyalgia; Peripheral vascular disease; Neurological disease; Post-radiation injuries
Organisation Name: Agencia de Evaluacion de Tecnologias Sanitarias
Contact Address: Instituto de Salud "Carlos III", Calle Sinesio Delgado 6, Pabellon 4, 28029 Madrid, Spain. Tel: +34 9 1 822 2005; Fax: +34 9 1 387 7841;
Contact Name: Luis M. Sánchez Gómez
Contact Email: luism.sanchez@isciii.es
Copyright: Agencia de Evaluacion
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.